Parkinson Disease At-Risk Study (PARS)
|
The Parkinson Associated Risk Syndrome (PARS) study is designed to evaluate a strategy for determining who may be at increased for Parkinson disease, Alzheimer disease or other neurologic conditions. This study is a large nationwide study led by investigators at IND to test the strategy of combining two biomarkers, olfaction(smell testing) and brain imaging, in older healthy adults to determine if this combination of testing offers a means to screen for early changes in the brain. |
Currently enrolling |
Brain Imaging Studies for Healthy Volunteers |
Many of the symptoms in Alzheimer disease and Parkinson disease relate to changes in specific neurochemicals in the brain. The imaging research program at IND is developing techniques to all for imaging these neurochemical changes. Healthy volunteers are critical to this research as it is necessary to compare the changes in the brain that occur with the brain of healthy individuals. |
Currently enrolling |